Last $58.96 USD
Change Today +0.47 / 0.80%
Volume 11.5M
MRK On Other Exchanges
Symbol
Exchange
New York
Mexico
EN Paris
Sao Paulo
Frankfurt
As of 8:04 PM 02/26/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Beth C. Seidenberg M.D.

Former Senior Executive in Research & Development, Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 116 board members in 16 different organizations across 19 different industries.

See Board Relationships
57--

Background*

Dr. Beth C. Seidenberg, M.D., is a Partner, General Partner, and Investment Partner at Kleiner Perkins Caufield & Byers. Dr. Seidenberg is a part of the life sciences team investing in digital health and biotech. She works with entrepreneurs to develop companies with breakthrough technology to treat patients and improve health. She joined the KPCB in 2005 and has incubated five companies. She serves as the Chairman and Founder of NVCA-MedIC coalition focusing on FDA ...

Read Full Background

Corporate Headquarters*

One Merck Drive
Whitehouse Station, New Jersey 08889

United States

Phone: 908-423-1000
Fax: --

Board Members Memberships*

Director
Director
Director
Chairperson
Director
Director
Director
Director
Director
Director
Chairperson
2005-2011
Former Independent Director, Chairman of Compensation Committee and Member of Corporate Governance & Nominating Committee
2008-Present
Independent Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
2011-Present
Director and Member of Audit Committee
2012-Present
Non-Employee Director and Chairman of Nominating & Corporate Governance Committee
2013-Present
Director
2014-Present
Director

Education*

BS
Barnard College
MD
University Of Miami School Of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $58.96 USD +0.47

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.3M
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.